Medifast Statistics

Total Valuation

Medifast has a market cap or net worth of GBP 132.50 million. The enterprise value is 8.81 million.

Market Cap	132.50M
Enterprise Value	8.81M

Important Dates

The next estimated earnings date is Friday, February 21, 2025.

Earnings Date	Feb 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	+0.31%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	9.40M

Valuation Ratios

The trailing PE ratio is 24.24.

PE Ratio	24.24
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	0.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 0.34, with an EV/FCF ratio of 0.35.

EV / Earnings	1.61
EV / Sales	0.02
EV / EBITDA	0.34
EV / EBIT	0.46
EV / FCF	0.35

Financial Position

The company has a current ratio of 3.11, with a Debt / Equity ratio of 0.09.

Current Ratio	3.11
Quick Ratio	2.35
Debt / Equity	0.09
Debt / EBITDA	0.55
Debt / FCF	0.52
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 3.66% and return on invested capital (ROIC) is 6.63%.

Return on Equity (ROE)	3.66%
Return on Assets (ROA)	4.77%
Return on Capital (ROIC)	6.63%
Revenue Per Employee	793,732
Profits Per Employee	8,620
Employee Count	634
Asset Turnover	2.21
Inventory Turnover	3.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -70.54% in the last 52 weeks. The beta is 1.16, so Medifast's price volatility has been higher than the market average.

Beta (5Y)	1.16
52-Week Price Change	-70.54%
50-Day Moving Average	17.98
200-Day Moving Average	20.76
Relative Strength Index (RSI)	41.48
Average Volume (20 Days)	327

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.18

Income Statement

In the last 12 months, Medifast had revenue of GBP 503.23 million and earned 5.47 million in profits. Earnings per share was 0.50.

Revenue	503.23M
Gross Profit	371.39M
Operating Income	17.42M
Pretax Income	9.19M
Net Income	5.47M
EBITDA	20.17M
EBIT	17.42M
Earnings Per Share (EPS)	0.50

Full Income Statement

Balance Sheet

The company has 126.80 million in cash and 13.15 million in debt, giving a net cash position of 113.65 million.

Cash & Cash Equivalents	126.80M
Total Debt	13.15M
Net Cash	113.65M
Net Cash Per Share	n/a
Equity (Book Value)	154.70M
Book Value Per Share	14.52
Working Capital	113.85M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 29.80 million and capital expenditures -4.56 million, giving a free cash flow of 25.24 million.

Operating Cash Flow	29.80M
Capital Expenditures	-4.56M
Free Cash Flow	25.24M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 73.80%, with operating and profit margins of 3.46% and 1.09%.

Gross Margin	73.80%
Operating Margin	3.46%
Pretax Margin	1.83%
Profit Margin	1.09%
EBITDA Margin	4.01%
EBIT Margin	3.46%
FCF Margin	5.02%

Dividends & Yields

Medifast does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	255.19%
Buyback Yield	-0.03%
Shareholder Yield	-0.03%
Earnings Yield	4.12%
FCF Yield	19.05%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medifast has an Altman Z-Score of 7.2.

Altman Z-Score	7.2
Piotroski F-Score	n/a